This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
March 15, 2018
Onxeo to Present Results of Two Studies Highlighting Potential of AsiDNA™ as Anti-Cancer Treatment at 2018 AACR Annual Meeting
March 15, 2018
Targovax ASA: Notice of Annual General Meeting
March 14, 2018
Onxeo Provides Financial Update
March 12, 2018
Strongbridge Biopharma plc Reports Full-Year 2017 Financial Results
March 12, 2018
Nordic Nanovector to Present at the China Healthcare Investing & Partnering Symposium in China and Stifel Nordic Healthcare Seminar in London
March 12, 2018
Altimmune Announces Pre-Clinical Data From its SparVax-L Anthrax Vaccine Program
March 12, 2018
Wilson Therapeutics announces agenda for Capital Markets Day on 21 March 2018
March 07, 2018
Strongbridge Biopharma Investor and Analyst Day – Save the Date
March 07, 2018
Approval to launch the Phase I Study of repeated and increasing doses to assess CER-209 in NASH/NAFLD
March 07, 2018
NEXSTIM PLC PUBLISHES 2017 ANNUAL REPORT